We are live on
!
Find out more
EVLO
Evelo Biosciences, Inc. Common Stock
EVLO
EVLO
Delisted
EVLO was delisted on the 11th of December, 2023.
46 hedge funds and large institutions have $180M invested in Evelo Biosciences, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 20 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
312% more call options, than puts
Call options by funds: $210K | Put options by funds: $51K
12% more capital invested
Capital invested by funds: $161M → $180M (+$19.3M)
32% less funds holding
Funds holding: 68 → 46 (-22)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
50% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 20
70% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 27
Holders
46
Holders Change
-22
Holders Change %
-32.35%
% of All Funds
0.77%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
8
Increased
10
Reduced
20
Closed
27
Calls
$210K
Puts
$51K
Net Calls
+$159K
Net Calls Change
+$331K
Top Buyers
Top Sellers
| 1 |
BlackRock
New York
|
-$2.67M |
| 2 |
State Street
Boston,
Massachusetts
|
-$1.12M |
| 3 |
Group One Trading
Chicago,
Illinois
|
-$997K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$498K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$470K |
